Zusammenfassung
Als hepatotrop bezeichnet man Viren, deren primäres Zielorgan die Leber ist. Zu ihnen zählen in erster Linie die Hepatitisviren A, B, C, D und E. Die Bedeutung der „neuen“ Hepatitisviren HGV/GBV-C, TTV und SENV für den Menschen lässt sich derzeit noch nicht vollständig beurteilen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aggarwal R, Krawczynsky K (2000) Hepatitis E. An overview and recent advances in clinical and laboratory research. J Gastroenterol Hepatol 15: 9–20
Alt M, Renz R, Hofschneider PH et al. (1995) Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides. Hepatology 22: 707–717
Bowden S (2001) New hepatitis viruses: contenders and pretenders. J Gastroenterol Hepatol 16: 124–131
Chen PJ (1986) Structure and replication of the genome of hepatitis delta virus. Proc Natl Acad Sci USA 83: 8774–8778
Dienstag JL, Isselbacher JK (1994) Acute hepatitis. In: Isselbacher KJ et al. (eds) Harrison’s principles of internal medicine. McGraw-Hill, New York
Encke J, zu Putlitz J, Wands JR (1999) DNA vaccines. Intervirology 42: 117–124
Fields DM, Knipe PM, Howley PM (1996) Fields virology, 3rd ed. Lippincott-Raven, Philadelphia
Hoofnagle JH, Lau D (1997) New therapies for chronic hepatitis B. J Viral Hepatitis 4 [suppl 1]: 41–50
Irshad M (1999) Hepatitis E virus: an update on its molecular, clinical and epidemiological characteristics. Intervirology 42:252–262
Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 354: 41–52
Lee J-H, Sarrazin C, Sarrazin U (2000) Experimentelle Therapieansätze bei chronischer Hepatitis Bund C. In: Zeuzem S (Hrsg) Chronische Virushepatitiden. Biologie, Diagnostik und Therapie. Uni med Verlag, Bremen
Lee WM (1997) Hepatitis B virus infection. N Engl J Med 337: 1733–1745
Lemon SM (1997) Type A viral hepatitis:epidemiology, diagnosis and prevention. Clinical Chemistry 43: 1494–1499
Mast EE, Alter MJ, Holland PV et al. (1998) Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatology 27: 857–861
Meng XJ, Purcell RH, Halbur PG et al. (1997) A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci USA 94: 9860–9865
Nassal M (1999) Hepatitis B virus replication: novel roles for virus-host interactions. Intervirology 42: 100–116
Pianko S, McHutchison J (1999) Chronic hepatitis B: new therapies on the horizon? Lancet 354: 1662–1663
Rizzetto M (1983) The delta agent. Hepatology 3: 729
Robertson BH, Jansen RW, Khanna B et al. (1992) Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol 73: 1365–1377
Robinson WS (1996) Biology of human hepatitis viruses. In: Zakim D, Boyer TD (eds) Hepatology. A textbook of liver disease, 3rd ed. Saunders, Philadelphia
Sakamoto N, Wu CH, Wu GY (1996) Intracellular cleavage of hepatitis C virus RNA and inhibition of viral protein translation by hammerhead ribozymes. J Clin Invest 98: 2720–2728
Sarrazin C, Roth WK, Zeuzem S (1998) GB-Virus C/Hepatitis G-Virus-Entdeckung, Epidemiologie, Diagnostik und klinische Relevanz. Z Gastroenterol 36: 997–1008
Sarrazin C, Zeuzem S (2000) Molekular-und Immunbiologie. In: Zeuzem S (Hrsg) Chronische Virushepatitiden. Biologie, Diagnostik und Therapie. Uni med Verlag, Bremen
Sarrazin U, Zeuzem S (2000) Therapie der chronischen Hepatitis Bund D. In: Zeuzem S (Hrsg) Chronische Virushepatitiden. Biologie, Diagnostik und Therapie. Uni med Verlag, Bremen
Sarrazin U, Sarrazin C (2000) Serologische und molekulare Diagnostik. In: Zeuzem S (Hrsg) Chronische Virushepatitiden. Biologie, Diagnostik und Therapie. Uni med Verlag, Bremen
Sjogren MH (1996) Serologie diagnosis of viral hepatitis. Med Clin North Am 80: 929–956
Spangenberg HC, Wands JR (2001) Ribozymes and hepatitis B virus. J Gastroenterol Hepatol 16: 1084–1085
Tarn AW, Smith MM, Guerra ME et al. (1991) Hepatitis E virus (HEV): molecular cloning and sequeneing of the full-Iength viral genome. Virology 185: 120–131
Taylor JM (1999) Hepatitis delta virus. Intervirology 42: 173–178
Tillmann HL, Heiken H, Knapik-Botor A et al. (2001) Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 345: 761–762
Totsuka A, Moritsugu Y (1999) Hepatitis A virus proteins. Intervirology 42: 63–68
Von Weizsücker F, Wieland S, Käck J et al. (1997) Gene therapy for chronic viral hepatitis:ribozymes, antisense oligonuc1eotides, and dominant negative mutants. Hepatology 26: 251–255
Zaaijer HL, Ter Borg F, Cuypers HTM et al. (1994) Comparison of methods for detection of hepatitis B virus DNA. J Clin Microbiol 32: 2088–2091
Zakim D, Boyer TD (eds) (1996) Hepatology, a textbook of liver disease, vol II, 3rd ed. Saunders, Philadelphia
Zeuzem S (2000) Therapie der chronischen Hepatitis C. In: Zeuzem S (Hrsg) Chronische Virushepatitiden. Biologie, Diagnostik und Therapie. Uni med Verlag, Bremen
Zeuzem S, Roth WK, Herrmann G (1995) Virushepatitis C. Z Gastroenterol 33: 117–132
Alter M, Gallagher M, Morris TT et al. (1997) Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 336: 741–746
Altmann HW (1971) Die Histologie der akuten Hepatitis. In: Wannagat L (Hrsg) Die akute Hepatitis. Thieme, Stuttgart, S41–61
Ballardini G, Groff P, Giostra F et al. (1995) Hepatocellular codistribution of c100, c33, c22 and NS 5 hepatitis C virus antigen detected by using immunopurified polyclonal spontaneous antibodies. Hepatology 21: 730–734
Beinker NK, Voigt MD, Arendse M et al. (1996) Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis Band C. J Hepatol 25: 633–638
Bianchi L, de Groote J, Desmet VJ et al. (1971) Morphological criteria in viral hepatitis. Lancet I: 333–337
Blight K, Rowland, Hall PD (1993) Immunohostochemical detection of the NS 4 antigen of hepatitis C virus and its relation to histopathology. Am J Pathol 143: 1568–1573
Boucher E, Bourienne A, Adams P et al. (1997) Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment. Gut 41: 11 5–120
Boyer JL, Klatskin G (1970) Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic) necrosis. N Engl J Med 283: 1063–1071
Chen TJ, Liaw YF (1988) The prognostic significance of bridging hepatic necrosis in chronic type B hepatitis; a histopathologic study. Liver 8: 10–16
Clouston AD, Jonsson JR, Purdie DM et al. (2001) Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation. J Hepatol 34: 314–320
Czaja AJ, Carpenter HA, Santrach PJ et al. (1998) Host-and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol 29: 198–206
De Groote J, Desmet VJ, Gedigk T et al. (1968) A classification of chronic hepatitis. Lancet II: 626–628
Desmet VJ, Gerber M, Hoofnagle JH et al. (1994) Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19: 1513–1520
Dienes HP, Popper H, Arnold W et al. (1982) Histologic observations in human hepatitis non-A, non-B. Hepatology 2: 562–571
Dries V, von Both I, Müller M et al. (1999) Detection of he pat itis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum. Hepatology 29: 223–229
Dries V, Odenthal M, Schirmacher P et al. (2001) Bioptische Diagnostik der Hepatitis C. Morphologie, Molekularpathologie und klinisch-therapeutische Implikationen. Pathologe 22:362–368
Fontaine H, Nalpas B, Poulet B et al. (2001) Hepatitis activity index is a key factor in determining the natural history of chronic hepatitis C. Hum Pathol 32: 904–909
Foschini MP, Morandi L, Macchia S et al. (2001) TT virus-related acute recurrent hepatitis. Histological features of a case and review of the literature. Virchows Arch 439: 752–755
Foster GR, Goldin RD, Main J et al. (1997) Management of chronic hepatitis C: clinical audit of biopsy based management algorithm. BMJ 315: 453–458
Gerber MA (1998) Pathology of acute viral hepatitis. In: Goldin RD, Thomas HC, Gerber MA (eds) Pathology of viral hepatitis. Arnold, London Sydney Auckland, pp 15–27
Goldin RD, Levine TS, Foster GR et al. (1996) Granulomas and hepatitis C. Histopathology 28: 265–267
Goodman ZD, Ishak KG (1995) Histopathology of hepatitis C infection. Semin Liver Dis 15: 70–81
Gudat F, Bianchi L, Sonnabend W et al. (1975) Pattern of core and surface expression in liver tissue reflects state of specific immune response in hepatitis B. Lab Invest 32: 1–9
Healey CJ, Chapman RWG, Fleming KA (1995) Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases. Gut 37: 274–278
Hourigan LF, Macdonald GA, Purdie et al. (1999) Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis. Hepatology 29: 1215–1219
Hübscher SG (1998) Histological grading and staging in chronic hepatitis: clinical applications and problems. J Hepatol 29: 1015–1022
Ikawa H, Hayashi Y, Ninomiya T et al. (2001) Various scoring systems evaluating histologic features of chronic hepatitis C treated with interferon. Hum Pathol 32: 910–917
International Working Party (1994) Terminology of chronic hepatitis, hepatic allograft rejection and nodular lesions of the liver: summary and recommendations developed by an international working party, supported by the World Congress of Gastroenterology, Los Angeles, 1994. Am J Gastroenterol 89: S177–181
Ishak KG (1976) Light microscopic morphology of viral hepatitis. Am J Clin Pathol 65: 787–796
Ishak KG (1994) Chronic hepatitis: morphology and nomenclature. Mod Pathol 7: 690–713
Ishak KG, Baptista A, Bianchi L et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22: 696–699
Koukoulis GK (2001) Chronic hepatitis C: grading, staging, and searching for reliable predictors of outcome. Hum Pathol 32: 899–903
Lindh M, Savage K, Rees J et al. (1999) HBeAg immunostaining of liver tissue in various stages of chronic hepatitis B. Liver 19:294–298
Mihm S, Fayyazi A, Hartmann H et al. (1997) Analysis of his topathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology 25: 735–739
Miyakawa Y, Mayumi M (1997) Hepatitis G virus — a true hepatitis virus or an accidental tourist? N Engl J Med 336: 795–796
Mochizuki K, Hayashi N, Hiramatsu Net al. (1996) Fas antigen expression im liver tissues of patients with chronic hepatitis B. J Hepatol 24: 1–7
Mosnier JF, Degott C, Marcellin P et al. (1993) The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology 17: 366–371
Park YN, Han KH, Kim KS et al. (1999) Cytoplasmic expression of hepatitis B core antigen in chronic hepatitis B virus infection: role of precore stop mutants. Liver 19: 199–205
Phillips MJ, Poucell S (1981) Modern aspects of the morphology of viral hepatitis. Hum Pathol 12: 1060–1084
Popper H, Paronetto F, Schaffner F (1965) Immune processes in the pathogenesis of liver diseases. Ann NY Acad Sci 124: 781–799
Poulsen H, Christoffersen P (1969) Abnormal bile duct epithelium in liver biopsies with histological signs of viral hepatitis. Acta Path Microbiol Scand 76: 383–390
Rodriguez-Inigo E, Casqueiro M, Bartolome J et al. (2000) Detection of TT virus DNA in liver biopsies by in situ hybridization. Am J Pathol 156: 1227–1234
Rubbia-Brandt L, Quadri R, Abid K et al. (2000) Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 33: 106–115
Scheuer PJ (1991) Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13: 372–374
Schlichting P, Holund B, Poulsen H (1983) Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen. Scand J Gastroenterol 18: 27–32
Sherman KE, Lewey SM, Goodman ZD (1995) Talc in the liver of patients with chronic hepatitis C infection. Am J Gastroenterol 90: 2164–2166
Texeira MR, Weller IV, Murray A et al. (1982) The pathology of hepatitis A in man. Liver 2: 53–60
Zeuzem S, Roth WK, Herrmann G (1995) Virushepatitis C. Z Gastroenterol 33: 117–132
Bader TF (1996) Hepatitis A vaccine. Am J Gastroenterol 91: 217–222
Bekkering FC, Brouwer JT, Leroux-Roels G et al. (1998) Ultra-rapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy. J Hepatol 28: 960–964
Bernstein D, Kleinman L, Barker C et al. (2002) Relationship of health-related quality of life to adherence and sustained response in chronic hepatitis C patients. Hepatology 35: 704–708
Böker KHW, Manns MP (1997) Was bringt die Interferontherapie bei der chronis chen Hepatitis? Internist 38: 191–203
Camma C, Giunta M, Pinzello G et al. (1999) Chronic hepatitis C and interferon alpha: conventional and cumulative meta-analyses of randomized controlled trials. Am J Gastroenterol 94: 581–595
Chow WC, Lee ASG, Lim GK et al. (1997) Acute viral hepatitis E: clinical and serologic studies in Singapore. J Clin Gastroenterol 24: 235–238
Czaja AJ (1997) Extrahepatic immunologic features of chronic viral hepatitis. Dig Dis 15: 125–144
Dancygier H, Frühauf H (1997) Klinische Pharmakologie der Leberkrankheiten. In: Kuemmerle (Hrsg) Klinische Pharmakologie, 4. Aufl, Kap. IV-4.11.1. Klinische Pharmakologie der Leberkrankheiten, 53. Erg.-Lfg. 11197. Ecomed, Landsberg/Lech
Davis GL, Esteban-Mur R, Rustgi V et al. (1998) Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 339: 1493–1499
Foster GR, Finter NB (1998) Are all type I human interferons equivalent? J Viral Hepat 5: 143–152
Glue P, Jane WSF, Rouzier-Panis R et al. (2000) Pegylated interferon-α-2b: pharmacokinetics, pharmacodynamics, safety, and a preliminary efficacy data. Clin Pharmacol Ther 68: 556–567
Häussinger D, Niederau C (Hrsg) (1997) Hepatitis C. Blackwell Wissenschafts-Verlag, Berlin
Heathcote J (1998) Consensus interferon: a novel interferon for the treatment of hepatitis C. J Viral Hepat 5 [suppl 1): 13–18
Heathcote EJ, Shiffman ML, Cooksley W et al. (2000) Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med 343: 1673–1680
Hopf U, Niederau C, Kleber G et al. (1997) Behandlung der chronischen Virushepatitis B/D und der akuten und chronischen Hepatitis C. Konsensus der Deutschen Gesellschaft för Verdauungs-und Stoffwechselkrankheiten. Z Gastroenterol 35: 971–986
Ikeda K, Saitoh S, Arase Y et al. (1999) Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis. Hepatology 29: 1124–1130
Jaeckel E, Cornberg M, Wedemeyer H et al. (2001) Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med 345: 1452–1457
Koff RS (1998) Hepatitis A. Lancet 241: 1643–1649
Krawczynski K (1993) Hepatitis E. Hepatology 17: 932–941
Lee WM (1997) Hepatitis B virus infection. N Engl J Med 337: 1733–1745
Lemon SM, Thomas DL (1997) Vaccines to prevent viral hepatitis. N Engl J Med 336: 196–204
Lindsay KL, Trepo C, Heintges T et al. (2001) A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C. Hepatology 34: 395–403
Lok AS, Heathcote EJ, Hoofnagle JH (2001) Management of hepatitis B: 2000 — summary of a workshop. Gastroenterology 120: 1828–1853
Malik AH, Lee WM (2000) Chronic hepatitis B virus infection: treatment strategies for the next millennium. Ann Intern Med 132: 723–731
Manns MP, McHutchison JG, Gordon SC et al. (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358: 958–965
McHutchison JG, Gordon SC, Schiff ER et al. (1998) Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 339: 1485–1492
Neumann AU, Lam NP, Dahari H et al. (1998) Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282: 103–107
Palmer JP (1997) Treatment of chronic hepatitis C with amantadine. Dig Dis Sci 42(8): 1681–1687
Perry MP, Jarvis B (2001) Peginterferon-α-2a (40kD) A review of its use in the management of chronic hepatitis C. Drugs 61:2263–2288
Poynard T, Marcellin P, Lee SS (1998) Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT). Lancet 352: 1426–1432
Rambusch EG, Manns MP (1998) Extrahepatische Manifestationen der Hepatitis C-Infektion. Z Gastroenterol 36: 579–586
Robert-Koch-Institut (Hrsg) (1999) Zur Situation bei wichtigen Infektionskrankheiten im Jahr 1998 — Teil 2: Virushepatitiden. Epidemiologisches Bulletin 17 199 des Robert-Koch-Institus Berlin vom 30.4.1999, S 119-124
Tillmann HL, Manns MP (2000) Virustatikum für die Therapie der Hepatitis B mit geringem Nebenwirkungsprofil. Arzneimitteltherapie 18: 102–108
Vento S, Garofano T, Renzini C et al. (1998) Fulminant hepatitis associated with hepatitis A superinfection in patients with chronic hepatitis C. N Engl J Med 338: 286–290
Wedemeyer H, Jaeckel E, Wedemeyer J et al. (1998) Ist eine Kombinationstherapie der chronischen Hepatitis C mit Interferon alpha und Ribavirin bei primaren Interferon-Nonrespondern indiziert? — Eine Analyse der eigenen Erfahrungen und eine Zusammenfassung der Literatur. Z Gastroenterol 36: 819–827
Willson RA (1997) Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol 92: 4–17
Wu JC, Sheen IJ, Chiang TY et al. (1998) The impact of traveling to endemic areas on the spread of hepatitis E virus infection: epidemiological and molecular analyses. Hepatology 27: 1415–1420
Zeuzem S, Roth WK, Herrmann G (1995) Virushepatitis C. Z Gastroenterol 33: 117–132
Zeuzem S, Feinman SV, Rasenack J (2000) Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med 343: 1666–1672
Zoulim F, Trepo C (1998) Drug therapy for chronic hepatitis B: antiviral efficacy and influence of hepatitis B virus polymerase mutations on the outcome of therapy. J Hepatol 29: 151–168
Carmichael GP, Zahradnik JM, Moyer GH et al. (1979) Adenovirus hepatitis in an immunsuppressed adult patient. Am J Clin Pathol 71: 352–355
Edington GM, White HA (1972) The pathology of Lassa fever. Trans R Soc Trop Med Hyg 66: 381–389
Edoute Y, Baruch Y, Lachter J et al. (1998) Case report: severe cholestatic jaundice induced by Epstein-Barr virus infection in the elderly. J Gastroenterol Hepatol 13: 821–824
Fabre A, Couvelard A, Degott C et al. (2001) Dengue virus induced hepatitis with chronic calcific changes. Gut 49: 864–865
Fingeroth JD (2000) Herpesvirus infection of the liver. Infect Dis Clin North Am 14: 689–719
Flewett TH, Parker RG, Philip WM (1969) Acute hepatitis due to herpes simplex virus in an adult. J Clin Pathol 22: 60–66
Francis TI, Moore DL, Edington GM et al. (1972) A clinicopathological study of human yellow fever. Bull WHO 46: 659–667
Goodman ZD, Ishak KG, Sesterhenn I (1986) Herpes simplex hepatitis in apparendy immunocompetent adults. Am J Clin Pathol 85: 694–699
Heni N, Heissmeyer HH, Baumgartner M (1986) Klinik der Zytomegalie-Infektion des Erwachsenen. Dtsch Med Wochenschr 111:499–503
Kanno A, Abe M, Yamada M et al. (1997) Clinical and histological features of cytomegalovirus hepatitis in previously healthy adults. Liver 17: 129–132
Kaufman B, Ghandi SA, Louie E et al. (1997) Herpes simplex virus hepatitis: case report and review. Clin Infect Dis 24: 334–338
Kilpatrick ZM (1966) Structural and functional abnormalities of liver in infectious mononucleosis. Arch Intern Med 117: 47–53
Kimura H, Nagasaka T, Hoshino Y et al. (2001) Severe hepatitis caused by Epstein-Barr virus without infection of hepatocytes. Hum Pathol 32: 757–762
Klein NA, Mabie WC, Shaver DC et al. (1991) Herpes simplex virus hepatitis in pregnancy. Two patients successfully treated with acyclovir. Gastroenterology 100: 239–244
Krilov LR, Rubin LG, Frogel M et al. (1990) Disseminated adenovirus infection with hepatic necrosis in patients with human immunodeficiency virus infection and other immunodeficiency states. Rev Infect Dis 12: 303–307
Langnas AN, Markin RS, Cattral MS et al. (1995) Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology 22: 1661–1665
Lichtenstein PK, Heubi JE, Daugherty CC et al. (1983) Grade I Reye’s syndrome. A frequent cause of vomiting and liver dysfunction after varicella and upper-respiratory-tract infection. N Engl J Med 309: 133–139
Markin RS (1998) Hepatitis from non-hepatotropic viruses. In: Goldin RD, Thomas HC, Gerber MA (eds) Pathology of viral hepatitis. Arnold, London Sydney Auckland, pp 115–138
McLellan RK, Gleiner JA (1982) Acute hepatitis in an adult with rubeola. JAMA 247: 2000–2001
Meng G, Lan Y, Nakagawa M et al. (1997) High prevalence of hantavirus infection in a group of Chinese patients with acute hepatitis of unknown aetiology. J Viral Hep 4: 231–234
Phillips MJ, Blendis LM, Poucell S et al. (1991) Syncytial giantcell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features. N Engl J Med 324: 455–460
Shaw NJ, Evans JH (1988) Liver failure and Epstein-Barr virus infection. Arch Dis Childhood 63: 432–433
Sun NC, Smith VC (1966) Hepatitis associated with myocarditis: unusual manifestations of infection with coxsackie group B, type 3. N Engl J Med 274: 190–193
Yoto Y, Kudoh T, Haseyama K et al. (1996) Human parvovirus B19 infection associated with acute hepatitis. Lancet 347: 868–869
Adams JS, Walker DH (1981) The liver in Rocky Mountain spotted fever. Am J Clin Pathol 75: 156–161
Altemeier WA, Schowengerdt CG, Whiteley DH (1970) Abscesses of the liver. Surgical considerations. Arch Surg 101: 258–266
Alvarez SZ (1998) Hepatobiliary tuberculosis. J Gastroenterol Hepatol 13: 833–839
Alvarez SZ, Carpio R (1983) Hepatobiliary tuberculosis. Dig Dis Sci 28: 193–200
Chavenet P, Pillon D, Lancon JP et al. (1987) Granulomatous hepatitis associated with Lyme disease. Lancet II: 623–624
Chen C, Chen PJ, Yang PM et al. (1997) Clinical and microbiological features of liver abscess after trans arterial embolization for hepatocellular carcinoma. Am J Gastroenterol 92: 2257–2259
Dan M, Tyrrell LDJ, Goldsand G (1987) Isolation of chlamydia trachomatis from the liver of a patient with prolonged fever. Gut 28: 1514–1516
Dancygier H (1991) Umschriebene Lebererkrankungen (Abszesse, Zysten, Echinokokkose). In: Classen M, Diehl V, Kochsiek K (Hrsg) Innere Medizin. Urban & Schwarzenberg, München Wien Baltimore, S 609–615
De la Vega M, Rivero JC, Su’arez S (2001) A fish bone in the liver. Lancet 358: 982
Diem LV, My TQ, Chi NV et al. (1976) Typhoid fever with hepatitis. J Trop Med Hyg 79: 25–27
Dienes HP (2000) Hepatitis. In: Denk H, Dienes HP, Düllmann J et al. (Hrsg) Pathologie der Leber und der Gallenwege. Springer, Berlin Heidelberg New York, S 317–441
Dugger K, Leby T, Brus M et al. (1990) Hepatic abscess resulting from gastric perforation of a foreign object. Am J Emerg Med 8: 323–325
El-Newihi H, Alamy ME, Reynolds TB (1996) Salmonella hepatitis: analysis of 27 cases and comparison with acute viral hepatitis. Hepatology 24: 516–519
Essop AR, Posen JA, Hodkinson JH et al. (1984) Tuberculous hepatitis. A clinical review of 96 cases. QJM 53: 465–477
Ferreira VA, Vianna MR, Yasuda PH et al. (1987) Detection of leptospiral antigen in the human liver and kidney using an immunoperoxidase staining procedure. J Pathol 151: 125–131
Fogel R, Lewis S (1960) Diagnosis of brucella melitensis infection by percutaneous needle biopsy of the liver. Ann Intern Med 53: 204–215
Gourley GR, Chesney PJ, Davis JP et al. (1981) Acute cholestasis in patients with toxic shock syndrome. Gastroenterology 81: 928–931
Greenstein AJ, Sachar DB (1988) Pyogenic and amebic abscesses of the liver. Semin Liver Dis 8: 210–217
Greenwald KA, Nash G, Foley FD (1969) Acute systemic melioidosis. Autopsy findings in four patients. Am J Clin Pathol 52: 188–198
Horowitz HW, Dworkin B, Forseter G et al. (1996) Liver function in early Lyme disease. Hepatology 23: 1412–1417
Ishak KG, Rogers WA (1981) Cryptogenic acute cholangitis — association with toxic shock syndrome. Am J Clin Pathol 76: 619–626
Judge DM, Samuel I, Perine PL et al. (1974) Louse-born relapsing fever in man. Arch Pathol Lab Med 97: 136–140
Karat ABA, Job CK, Rao PSS (1971) Liver in leprosy: histological and biochemical findings. Br Med J 1(744): 307–310
Khan M, Coovadia Y, Sturm AW (1998) Typhoid fever complicated by acute renal failure and hepatitis: case reports and review. Am J Gastroenterol 93: 1001–1003
Khosla SN (1990) Typhoid hepatitis. Postgrad Med J 66: 923–925
Kimball MW, Knee S (1970) Gonococcal perihepatitis in a male. N Engl J Med 282: 1082–1083
Lam KH, Wong SK, Lee DW et al. (1999) ERCP and pyogenic liver abscess. Gastrointest Endosc 50: 340–344
Leelarasamee A, Bovornkitti S (1989) Melioidosis: review and update. Rev Infect Dis 11: 413–425
Maharaj B, Leary WP, Pudifin DJ (1987) A prospective study of hepatic tuberculosis in 41 black patients. QJM 63: 517–522
Marino P, Maggioni M, Preatoni A et al. (1996) Liver abscesses due to listeria monocytogenes. Liver 16: 67–69
McDonald MI, Corey GR, Gallis HA et al. (1984) Single and multiple pyogenic liver abscesses. Natural history, diagnosis and treatment with emphasis on percutaneous drainage. Medicine (Baltimore) 63: 291–302
Mongiardo N, de Rienzo B, Zonchetta G et al. (1986) Primary hepatic actinomycosis. J Infect 8: 65–69
Ochsner A, De Bakey M, Murray S (1938) Pyogenic abscesses of the liver. II. An analysis of forty-seven cases with review of the literature. Am J Surg 40: 292–319
Piggot JA, Hochholzer L (1970) Human melioidosis. A histopathologic study of acute and chronic melioidosis. Arch Pathol Lab Med 90: 101–111
Pramoolsinsap C, Viranuvatti V (1998) Salmonella hepatitis. J Gastroenterol Hepatol 13: 745–750
Putnam HC, Dockerty MB, Waugh JM (1950) Abdominal actinomycosis. Surg 28: 781–800
Rajak CL, Gupta S, Jain S et al. (1998) Percutaneous treatment of liver abscesses: needle aspiration versus catheter drainage. Am J Roentgenol 170: 1035–1039
Seeto RK, Rockey DC (1996) Pyogenic liver abscess. Changes in etiology, management, and outcome. Medicine (Baltimore) 75: 99–113
Srinivasan A, Kraus CN, DeShazer D et al. (2001) Glanders in a military research microbiologist. N Engl J Med 345: 256–258
Steere AC, Bartenhagen NH, Craft JE et al. (1983) The earlyclinical manifestations of Lyme disease. Ann Intern Med 99: 76–82
Tazawa J, Sakai Y, Maekawa S et al. (1997) Solitary and multiple pyogenic liver abscesses: characteristics of the patients and efficacy of percutaneous drainage. Am J Gastroenterol 92: 271–274
Weil A (1886) Über eine eigentümliche mit Milztumor, Icterus und Nephritis einhergehende akute Infektionskrankheit. Dtsch Arch Klin Med 39: 209
Williams RK, Crossley K (1982) Acute and chronic hepatic involvement of brucellosis. Gastroenterology 83: 455–458
Yang CC, Chen CY, Lin XZ et al. (1993) Pyogenic liver abscess in Taiwan: emphasis on gas-forming liver abscess in diabetics. Am J Gastroenterol 88: 1911–1915
Yu VL, Miller WP, Wing EJ et al. (1982) Disseminated listeriosis presenting as acute hepatitis. Am J Med 73: 773–777
Badalamenti S, Jameson JE, Reddy KR (1999) Amebiasis. Curr Treat Opt Gastroenterol 1: 97–103
Crane GG (1986) Hyperreactive malarious splenomegaly (tropical splenomegaly syndrome). Parasitol Today 2: 4–9
Greenstein AJ, Sachar DB (1988) Pyogenic and amebic abscesses of the liver. Semin Liver Dis 8: 210–217
Knight R (1984) Hepatic amebiasis. Semin Liver Dis 4: 277–292
Li E, Stanley SL (1996) Amebiasis. Gastroenterol Clin North Am 25: 47l–492
Pampiglione S, Manson-Bahr PEC, Giungi F et al. (1974) Studies in mediterranean leishmaniasis 2. Asymptomatic cases of visceral leishmaniasis. Trans R Soc Trop Med Hyg 68: 447–453
Pradel G, Frevert U (2001) Malaria sporozoites actively enter and pass through rat Kupffer cells prior to hepatocyte invasion. Hepatology 33: 1154–1165
Reed SL (1992) Amebiasis: an update. Clin Infect Dis 14: 385–393
Sharma MP, Dasarathy S, Verma N et al. (1996) Prognostic markers in amebic liver abscess: a prospective study. Am J Gastroenterol 91: 2584–2588
Teutzner KH, Treumann T, Winkeltau G et al. (1989) Die parasitäre Leberzyste. Leber Magen Darm 19: 111–124
Tiwari I, Roland CF, Popple AW (1982) Cholestatic jaundice due to toxoplasma hepatitis. Postgrad Med J 58: 299–300
Turrini F, Schwarzer E, Arese P (1993) The involvement of hemozoin toxicity in depression of cellular immunity. Parasitol Today 9: 297–300
Weitberg AB, Alper JC, Diamond I et al. (1979) Acute granulomatous hepatitis in the course of acquired toxoplasmosis. N Engl J Med 300: 1093–1096
Aktan AÖ, Yalin R (1996) Preoperative albendazole treatment for liver hydatid disease decreases the viability of the cyst. Eur J Gastroenterol 8: 877–879
Andrade ZA, Peixoto E, Guerret S et al. (1992) Hepatic connective tissue changes in hepatosplenic schistosomiasis. Hum Pathol 23: 566–573
Bastid C, Azar C, Doyer M et al. (1994) Percutaneous treatment of hydatid cysts under sonographic guidance. Dig Dis Sci 39: 1576–1580
Beaver PC (1969) The nature of visceral larva migrans. J Parasitol 55: 3–12
Bhatia V, Sarin SK (1994) Hepatic visceral larva migrans: evolution of the lesion, diagnosis, and role of high-dose albendazole therapy. Am J Gastroenterol 89: 624–627
Bica I, Hamer DH, Stadecker MJ (2000) Hepatic schistosomiasis. Infect Clin North Am 14: 583–604
Camacho-Lobato L, Borges DR (1998) Early liver dysfunction in schistosomiasis. J Hepatol 29: 233–240
Chen MG, Mott KE (1990) Progress in assessment of morbidity due to Fasciola hepatica infection: a review of recent literature. Trop Dis Bull 87: Rl–37
Dessein AJ, Hillaire D, Eldin N et al. (1999) Severe hepatic fibrosis in schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am J Hum Genet 65: 709–721
Dovidar N, El Sayad M, Mervat O et al. (1999) Endoscopic therapy of fascioliais resistant to oral therapy. Gastrointest Endosc 50: 345–351
Frider B, Larrieu E, Odriozola M (1999) Long-term outcome of asymptomatic liver hydatidosis. J Hepatol 30: 228–231
Gil-Grande LA, Rodriguez-Caabeiro F, Prieto JG et al. (1993) Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet 342: 1269–1272
Goldring OL, Klegg JA, Smithers SR et al. (1976) Acquisition of human blood group antigens by schistosoma mansoni. Clin Exp Immunol 26: 181–187
Hernandez HJ, Wang Y, Tzellas N et al. (1997) Expression of class II, but not class I, major histocompatibility complex molecules is required for granuloma formation in infection with schistosoma mansoni. Eur J Immunol 27: 1170–1176
Hira PR, Lindberg LG, Francis I et al. (1988) Diagnosis of cystic hydatid disease: role of aspiration cytology. Lancet II: 655–657
Hou PC (1955) The pathology of clonorchis sinensis infestation of the liver. J Pathol 70: 53–64
Ishizu H, Uchino J, Sato N et al. (1997) Effect of albendazole on recurrent and residual alveolar echinococcosis of the liver after surgery. Hepatology 25: 528–531
Kaul V, Friedenberg F, Rothstein KD (2000) Hepatic cysts. Curr Treat Opin Gastroenterol 3: 349–343
Kern P, Kratzer W, Reuter S (2000) Alveoläre Echinokokkose: Diagnostik. Dtsch Med Wochenschr 125: 59–62
Kern P, Kratzer W, Reuter S (2000) Alveoläre Echinokokkose: Therapie. Dtsch Med Wochenschr 125: 87–89
Khuroo MS, Wani NA, Javid G et al. (1997) Percutaneous drainage compared with surgery for hepatic hydatid cysts. N Engl J Med 337: 881–887
Liu LX, Harinasuta KT (1996) Liver and intestinal flukes. Gastroenterol Clin North Am 25: 627–636
MacLean JD, Graeme-Cook FM (2002) A 50-year-old man with eosinophilia and fluctuating hepatic lesions. N Engl J Med 346: 1232–1239
Miguet JP, Bresson-Hadni S (1989) Alveolar echinococcosis of the liver. J Hepatol 3: 373–379
Samuelson JC, Sher A, Caulfield JP (1980) Newly transformed schistosomula spontaneously lose surface antigens and C3 acceptor sites during culture. J Immunol 124: 2055–2057
Schantz PM, Glickman LT (1978) Toxocaral visceral larva migrans. N Engl J Med 298: 436–439
Simpson AJ, Singer D, McCutchan TF et al. (1983) Evidence that schistosome MHC antigens are not synthesized by the parasite but are acquired from the host as intact glycoproteins. J Immunol 131: 962–965
Teutzner KH, Treumann T, Winkeltau G et al. (1989) Die parasitare Leberzyste. Leber Magen Darm 19: 111–124
Üstünsöz B, Akhan O, Kamiloglu MA et al. (1999) Percutaneous treatment of hydatid cysts of the liver: long term results. Am J Radiol 172: 91–96
Warren KS, Domingo EO (1970) Granuloma formation around schistosoma mansoni, S. haematobium and S. japonicum eggs. Site and rate of development, cellular composition, cross-sensitivity, and rate of egg destruction. Am J Trop Med Hyg 19: 292–304
Wilson JF, Rausch RL, Wilson FR (1995) Alveolar hydatid disease. Review of the surgical experience in 42 cases of active disease among Alaskan Eskimos. Ann Surg 221: 315–323
Goodwin RA, Shapiro JL, Thurman GH et al. (1980) Disseminated histoplasmosis: clinical and pathologic correlations. Medicine (Baltimore) 59: 1–33
Jain R, McLaren B, Bejarano P et al. (1996) Diagnostic problem in clinical hepatology. A 69-year-old man with cholestatic liver disease. Semin Liver Dis 16: 445–449
Redding PA, Gorelick DF, Brasher CA et al. (1970) Progressive disseminated histoplasmosis seen in adults. Am J Med 48: 629–636
Thaler M, Pastakia B, Shawker TH et al. (1988) Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med 108: 88–100
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Dancygier, H., Frühauf, H., Sarrazin, C., Sarrazin, U., Zeuzem, S. (2003). Infektiöse Lebererkrankungen. In: Klinische Hepatologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55902-0_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-55902-0_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-67559-4
Online ISBN: 978-3-642-55902-0
eBook Packages: Springer Book Archive